Location History:
- Phoenix, AZ (US) (2014)
- Chandler, AZ (US) (2014)
Company Filing History:
Years Active: 2014
Title: Lisa A De Meese: Innovator in Pharmaceutical Chemistry
Introduction
Lisa A De Meese is a prominent inventor based in Phoenix, AZ, known for her significant contributions to pharmaceutical chemistry. With a focus on developing innovative compounds, she has made strides in the field of kinase inhibitors and mTOR inhibitors. Her work is instrumental in advancing treatments for various diseases, including cancers.
Latest Patents
Lisa A De Meese holds 2 patents that showcase her expertise in creating novel therapeutic compounds. Her latest patents include:
1. **Triazolopyridine compounds as PIM kinase inhibitors** - These compounds are designed to inhibit receptor tyrosine kinases, which are crucial in the treatment of diseases mediated by PIM-1, PIM-2, and PIM-3 kinases.
2. **Substituted pyrazolo[1,5-a]pyrimidine compounds as mTOR inhibitors** - This patent involves compounds that inhibit mTOR, providing potential treatment options for diseases sensitive to mTOR inhibition, such as various cancers.
Career Highlights
Lisa is currently associated with Array Biopharma Inc., where she continues to innovate and develop new therapeutic solutions. Her work has garnered attention in the pharmaceutical industry, contributing to advancements in cancer treatment.
Collaborations
Throughout her career, Lisa has collaborated with notable colleagues, including Yvan Le Huerou and Eli M Wallace. These partnerships have enhanced her research and development efforts, leading to impactful innovations.
Conclusion
Lisa A De Meese exemplifies the spirit of innovation in pharmaceutical chemistry. Her patents and ongoing work contribute significantly to the development of effective treatments for serious diseases.